Evidence map›Paper›PMID 30220229›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2018

Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes.

Petar Žuvela, J Jay Liu, Myunggi Yi, Paweł P Pomastowski, Gulyaim Sagandykova, Mariusz Belka, Jonathan David, Tomasz Bączek, Krzysztof Szafrański, Beata Żołnowska and 4 more

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. The Study of Protein-Cyclitol Interactions.International journal of molecular sciences · 2022
    Article
  4. Interactions of Whey Proteins with Metal Ions.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Petar Žuvelaa Department of Chemistry , National University of Singapore , Singapore.ORCID http://orcid.org/0000-0001-6481-2241
J Jay Liuc Department of Chemical Engineering , Pukyong National University , Busan , Korea.
Myunggi Yid Department of Biomedical Engineering , Pukyong National University , Busan , Korea.
Paweł P Pomastowskib Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry , Nicolaus Copernicus University , Toruń , Poland.
Gulyaim Sagandykovae Interdisciplinary Centre for Modern Technologies, Nicolaus Copernicus University , Toruń , Poland.
Mariusz Belkaf Department of Pharmaceutical Chemistry , Medical University of Gdańsk , Gdańsk , Poland.
Jonathan Davida Department of Chemistry , National University of Singapore , Singapore.
Tomasz Bączekf Department of Pharmaceutical Chemistry , Medical University of Gdańsk , Gdańsk , Poland.
Krzysztof Szafrańskig Department of Organic Chemistry , Medical University of Gdańsk , Gdańsk , Poland.
Beata Żołnowskag Department of Organic Chemistry , Medical University of Gdańsk , Gdańsk , Poland.
Jarosław Sławińskig Department of Organic Chemistry , Medical University of Gdańsk , Gdańsk , Poland.
Claudiu T Supuranh Dipartimento di Chimica, Universita degli Studi di Firenze , Polo Scientifico, Laboratorio di Chimica Bioinorganica , Sesto Fiorentino (Florence) , Italy.ORCID http://orcid.org/0000-0003-4262-0323
Ming Wah Wonga Department of Chemistry , National University of Singapore , Singapore.
Bogusław Buszewskib Department of Environmental Chemistry and Bioanalytics, Faculty of Chemistry , Nicolaus Copernicus University , Toruń , Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a target-based drug screening method is proposed exploiting the synergy effect of ligand-based and structure-based computer-assisted drug design. The new method provides great flexibility in drug design and drug candidates with considerably lower risk in an efficient manner. As a model system, 45 sulphonamides (33 training, 12 testing ligands) in complex with carbonic anhydrase IX were used for development of quantitative structure-activity-lipophilicity (property)-relationships (QSPRs). For each ligand, nearly 5,000 molecular descriptors were calculated, while lipophilicity (logk

Indexed as

Molecular Docking SimulationAntigens, NeoplasmCarbonic Anhydrase IXChromatography, LiquidDrug Delivery SystemsDrug DiscoveryEnzyme InhibitorsHumansQuantitative Structure-Activity RelationshipSmall Molecule LibrariesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSulfanilamideSulfanilamidesAntigens, NeoplasmCA9 protein, humanCarbonic Anhydrase IXEnzyme InhibitorsSmall Molecule LibrariesSulfanilamideSulfanilamidescarbonic anhydrasesDrug discoveryinverse QSPRmolecular dockingmolecular dynamics

Identifiers

PMID30220229
PMCPMC6151961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.